Citi Lifts Target as Titan America Shorts Climb After Earnings Miss
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
TTAM closed Friday at $16.52, down 1.6% on the week, and just days after a Q1 earnings print that came in light on both revenue and EPS.
The results set an interesting backdrop. Q1 EPS of $0.18 missed the $0.20 consensus estimate. Revenue of $398.4M fell fractionally short of the $399.7M forecast. The stock initially jumped nearly 6% the day after the announcement before giving most of that back. Titan reaffirmed its full-year guidance of low-single-digit revenue growth — keeping the bull case alive while not offering much fresh fuel. Still up 10.3% on the month, the stock has recovered meaningfully from its April lows.
The short side has been quietly rebuilding since the earnings event. Short interest has risen roughly 4% over the past week to approximately 3.64 million shares, reversing a sharper decline through mid-April when shorts fell from above 4 million shares — a drop of around 12% over the prior month. At 14.8% of the free float, short positioning is material enough to warrant attention, especially given the recent directional shift. The ORTEX short score has ticked up to 74 from the low-70s over the past ten days, signalling growing short-side pressure rather than a easing. The borrow market, however, remains far from stressed. Availability is ample at around 249% of current short interest — well above any meaningful squeeze threshold — and the cost to borrow has actually eased over the month to just over 1%, down from the 1.7% range seen in late March and early April.
Options traders lean defensive but not dramatically so. The put/call ratio sits at 1.46, modestly above its 20-day average of 1.33, with a z-score of just 0.55 — elevated but not at an extreme. The 52-week high on the PCR is 1.56, so current readings are high-end-normal rather than a sharp outlier. Most of the PCR drift higher has come in the past few weeks, coinciding with the earnings period; the mid-April reading dipped below 0.8, which now looks like a brief period of calm before cautious positioning resumed. The combined picture from shorts and options is one of wariness rather than aggression: shorts are rebuilding incrementally, and options traders are hedging, but neither metric is at a level that implies a strong directional conviction.
Analyst sentiment got a clear boost on Friday. Citigroup raised its price target on TTAM to $20 from $19, maintaining its Buy rating — a direct response to the earnings release. The mean price target across the Street is $17.64, implying roughly 7% upside from current levels. Jefferies is also at $20 with a Buy, while Bernstein sits at $17 with a Market Perform. Not everyone is onside: Bank of America rates the stock Underperform with a $14 target, and Stifel is at Hold with $15. The PE of 14.8x and EV/EBITDA near 7.9x are not demanding multiples for a mid-cap construction materials name, and both have drifted slightly lower over the past 30 days, keeping the valuation case reasonably intact. The 14-day RSI of 52.8 points to neutral momentum — no overbought or oversold read to anchor the short-term view.
One signal worth flagging is the CFO's open-market purchase in March. The CFO bought 20,000 shares at $14.93, a $298,600 outlay, when the stock was trading well below current levels. That purchase preceded both the earnings beat-then-reaffirmation sequence and a 10%-plus monthly recovery — making it the most clearly timed insider activity in the recent record. Parent company Titan S.A. continues to hold 86.7% of the company, leaving a thin free float and contributing structurally to the elevated SI-as-percentage-of-float reading.
Among peers, MLM fell 3.9% on the week and VMC dropped 4.6%, making TTAM's 1.6% decline look relatively contained. CRH fared better, off just 1.5%. The degree of sector-wide weakness adds context to TTAM's post-earnings resilience — the stock held its ground in a tough tape for construction materials names broadly. The key watchpoint from here is whether short interest continues its recent rebuild or stalls as the post-earnings narrative stabilises around the reaffirmed guidance and the fresh Citi target.
Stocks in this article
See the live data behind this article on ORTEX.
Open TTAM on ORTEX →How this article was generated
- Generated
- 9 May 2026, 21:17
- Data as of
- 9 May 2026, 21:16
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signals
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.